Suchergebnisse - "O'Mahony, James F"

PubPharm (113)

21

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

enthalten in: PharmacoEconomics - open | 2022

von Fabbro, M. | Hahn, K. | Novaes, O. | +2

22

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

enthalten in: PharmacoEconomics - open | 2022

von Fabbro, M. | Hahn, K. | Novaes, O. | +2

23

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

enthalten in: PharmacoEconomics - open | 2022

von Fabbro, M. | Hahn, K. | Novaes, O. | +2

24

Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen : A model-based analysis for current and future disruptions

enthalten in: medRxiv : the preprint server for health sciences | 2022

von Burger, E. | de Kok, I. | O'Mahony, J. | +10

UpdateIn: Elife. 2022 Oct 12;11:. - PMID 36222673

25

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening : Intervention Eligibility, Strategy Choice, and Optimality

enthalten in: Medical decision making : an international journal of the Society for Medical Decision Making | 2022

von O'Mahony, J.

26

Cost-effectiveness evidence on approved cancer drugs in Ireland : the limits of data availability and implications for public accountability

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2022

von Almajed, S. | Alotaibi, N. | Zulfiqar, S. | +7

27

Cost-effectiveness evidence on approved cancer drugs in Ireland : the limits of data availability and implications for public accountability

enthalten in: The European journal of health economics | 2022

von Almajed, S. | Alotaibi, N. | Zulfiqar, S. | +7

28

Colorectal Cancer Screening within Colonoscopy Capacity Constraints : Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?

enthalten in: MDM policy & practice | 2022

von McFerran, E. | O'Mahony, J. | Naber, S. | +4

29

Revision of Ireland's Cost-Effectiveness Threshold : New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs

enthalten in: PharmacoEconomics - open | 2021

von O'Mahony, J.

30

Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability

enthalten in: The European journal of health economics | 2021

von Almajed, S. | Alotaibi, N. | Zulfiqar, S. | +7